Home » Newsletters » BioWorld Science

BioWorld Science

Jan. 20, 2022

View Archived Issues

Oncostatin M blockade ameliorates severe asthma

Targeting DICAM impedes migration of disease-inducing leukocytes into the CNS in multiple sclerosis

Nanodecoys scavenge RANKL and TNF-alpha for osteoporosis treatment

Kallyope presents new AMPK activators

Jiangsu Hengrui Medicine and Shanghai Hengrui Pharmaceutical patent new ATR kinase inhibitors

Sun Pharmaceutical Industries divulges GIPR and GLP-1 receptor dual agonists

Medshine Discovery synthesizes new JAK3 inhibitors

Red Bull GmbH presents dopamine reuptake inhibitors

DNA-PK activates survival kinase AKT in response to DNA damage

Targeting specific behavioral immune traits of inflammation

BATF promotes lung tissue protection during acute respiratory virus infection

Targeting PARP could fight cancer-associated virus

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 23, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...